DocGo Inc (DCGO) Stock Analysis
Verdict: AVOID
Massive revenue contraction and extreme net losses outweigh distressed valuation, creating a value trap until cash flow stabilizes.
Investment score: 32/100
Analysis as of
Is DocGo Inc stock worth reviewing? AI model thesis
Avoid due to severe fundamental deterioration and lack of price floor.
7-factor investment score
- Valuation: 45/100 (weight 20%)
- Financial Health: 15/100 (weight 15%)
- Technical Momentum: 10/100 (weight 15%)
- Earnings Quality: 50/100 (weight 15%)
- Insider Sentiment: 30/100 (weight 10%)
- Analyst Consensus: 40/100 (weight 10%)
- Risk-Adjusted Return: 25/100 (weight 15%)
DocGo Inc opportunities and risks
What speaks for DCGO
- Distressed Valuation Multiples
What speaks against DCGO
- Terminal Revenue Decline
Peers and competitors
| Ticker | P/E | P/S | EV/EBITDA | Gross margin | Net margin | FCF yield |
|---|---|---|---|---|---|---|
| DCGO | n/a | 0.0x | 0.5x | 30.5% | -21.5% | -31211480.5% |
| PARK | n/a | 0.4x | n/a | 10.9% | -1.4% | 5016.2% |
| NAKA | n/a | 2.2x | n/a | 14.2% | -1067.9% | -52.3% |
| PIII | n/a | 0.0x | n/a | 31.6% | -6.6% | -369.6% |
| IDXG | 0.3x | 1.2x | 8.7x | 63.7% | 67.6% | 9.3% |
| Peer median | n/a | 0.8x | n/a | 22.9% | -4.0% | -21.5% |
Frequently asked questions about DocGo Inc (DCGO)
Is DCGO stock a good investment?
The cached TradeMates AI model rates DocGo Inc as AVOID with an investment score of 32/100. Avoid due to severe fundamental deterioration and lack of price floor. This is algorithmic model output, not personal investment advice.
Is DCGO stock a buy?
The TradeMates model verdict for DCGO is AVOID with an investment score of 32/100. Treat this as a model signal to review, not a personal buy recommendation.